[ 18 F]FDG PET/CT in Patients Affected by SARS-CoV-2 and Lymphoproliferative Disorders and Treated with Tocilizumab.

Alberto Signore,Chiara Lauri,Maria Paola Bianchi,Sabrina Pelliccia, Andrea Lenza, Simone Tetti,Maria Luisa Martini, Gabriele Franchi, Fabio Trapasso,Luciano De Biase,Antonio Aceti,Agostino Tafuri

Journal of personalized medicine（2022）

引用 2|浏览5

暂无评分

摘要

In conclusion, in these two patients, interstitial pneumonia was efficiently treated with Tocilizumab, as demonstrated by the [F]FDG PET/CT. Our results confirm that interleukin-6 (IL6) has a role in the COVID-19 disease and that anti-cytokine treatment can also be performed in patients with lymphoproliferative disorders.

查看译文

关键词

COVID-19,SARS-CoV-2,[18F]FDG PET/CT,pneumonia,tocilizumab

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要